首页> 美国政府科技报告 >Assessing EphA2 and Ephrin-A as Novel Diagnostic and Prognostic Biomarkers of Prostate Cancer.

【24h】

Assessing EphA2 and Ephrin-A as Novel Diagnostic and Prognostic Biomarkers of Prostate Cancer.

机译：评估Epha2和Ephrin-a作为前列腺癌的新型诊断和预后生物标志物。

获取原文

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nguyen, C.;
展开▼
作者单位

展开▼
年度 2017
页码 1-11
总页数 11
原文格式 PDF
正文语种 eng
中图分类
关键词
Prostate cancer; African americans; Biological markers; Risk analysis; Biopsy; Predictions; Therapeutics; Patient care management; Diagnosis (medicine); Racial disparity; Health outcomes;

机译：前列腺癌;非裔美国人;生物标志物;风险分析;活组织检查;预测;治疗学;病人护理管理;诊断（医学）;种族差异;健康结果;

相似文献

外文文献
中文文献
专利

1. Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers [J] . Anika Kremer, Tobias Kremer, Glen Kristiansen, BMC Urology . 2019,第1期

机译：前列腺癌生物标志物研究的极限在哪里？对潜在的预后和诊断生物标志物的系统研究
2. Epigenetic events highlight the challenge of validating prognostic biomarkers during the clinical and biologic evolution of prostate cancer. [J] . Febbo PG Journal of Clinical Oncology . 2009,第19期

机译：表观遗传事件突出了在前列腺癌的临床和生物学进化过程中验证预后生物标志物的挑战。
3. Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer. [J] . Moul JW, Bettencourt MC, Sesterhenn IA, Surgery . 1996,第2期

机译：p53，bcl-2和KI-67（MIB-1）的蛋白表达作为通过手术治疗的临床局限性前列腺癌患者的预后生物标志物。
4. A Transcriptome-Wide Expression Study by Next-Generation Sequencing at the RIBOLUTION Biomarker Center Reveals Transcript Clusters with Prognostic Potential for Prostate Cancer [C] . Conny Blumert, Sabina Christ-Breulmann, Sven-Holger Puppel, International Molecular Medicine Tri-Conference. . 2016

机译：在罗缎生物标志物中心的下一代测序的转录组形表达研究揭示了前列腺癌预后潜力的转录簇
5. MicroRNAs as Prognostic Biomarkers in Prostate Cancer. [D] . Gordanpour, Aida. 2012

机译：MicroRNA作为前列腺癌的预后生物标志物。
6. Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers [O] . Anika Kremer, Tobias Kremer, Glen Kristiansen, 2019

机译：前列腺癌生物标志物研究的极限在哪里？对潜在的预后和诊断生物标志物的系统研究
7. Diagnostic value of SFRP1 as a favorable predictive and prognostic biomarker in patients with prostate cancer. [O] . Lei Zheng, Dongchen Sun, Wentao Fan, 2015

机译：sFRp1作为前列腺癌患者的有利预测和预后生物标志物的诊断价值。
8. Assessing EphA2 and Ephrin-A as Novel Diagnostic and Prognostic Biomarkers of Prostate Cancer. [R] . Nguyen, C. T. 2015

机译：评估Epha2和Ephrin-a作为前列腺癌的新型诊断和预后生物标志物。

Assessing EphA2 and Ephrin-A as Novel Diagnostic and Prognostic Biomarkers of Prostate Cancer.

著录项

引文网络

相似文献

相关主题

期刊订阅